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Background
Studies designed to promote unbiased research increas-
ingly show that human preferences exert a major influ-
ence on randomised controlled trials (RCTs) [1-3].
More information is needed on how preferences influ-
ence clinical trial design and conduction [4-6]. To fill
the information gap between what researchers seek and
report and what patients want [7,8], in this study we
investigated how researchers’ and patients’ preferences
influence study hypotheses and outcome results of pub-
lished clinical RCTs. Because conventional critical
appraisal seemed inappropriate for addressing our
research question, in this pilot study we developed a
novel assessment method and applied it in an RCT
sample.
Methods
We collected 20 unselected and consecutive RCTs pub-
lished in a high impact paediatric journal from July to
November 2013. Two experienced reviewers identified the
following five domains and a grading method to score
discrepancy between what author’s state in clinical trial
registries (CTRs) and report in published RCTs: reported
funding (1 point), study hypotheses, information on
patients enrolled and study conduction (3 points); primary
and secondary outcomes, early study completion, and
upgrading or downgrading outcome results (5 points).
Higher scores implied marked discrepancy. Two reviewers
then independently applied the method on the RCT sam-
ple by mapping and coding information for the domains
identified and reported discrepancies by comparing CTRs
and RCTs (Table S1, Additional file 1).
Results
Of the 20 RCTs collected and CTRs compared, 14 studies
had high total preference discrepancy scores (7 scored
10-12, and 7 scored 16 or more) and 4 had discrepancy
in declaring funding. In 12 studies researchers completed
the study early and in 8 studies they downgraded or
upgraded outcomes. Only 5 CTRs were updated but they
neglected to include published RCT results. Only in 5
CTRs, dataset supervisors indicated the RCT URL. None
of the 20 RCTs allowed us to assess patients’ preferences
(no information reported for non-response and refusal).
No difference was found in discrepancy scores among
the five CTR databases.
Conclusions
The high discrepancy scores obtained by comparing what
researchers stated in CTRs and published in RCTs sug-
gest possible misconduct. Patients’ preferences during
RCT enrolment and conduction remain undetectable
owing to the lack of targeted protocols to elicit this issue.
These results, if confirmed in further studies, should
prompt international regulation developers [2] to encou-
rage researchers to explore patients’ preferences as a
strategy to enhance informed decision-making and to
improve reporting in RCTs and CTRs.
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